Calcium influences sensitivity to growth inhibition induced by a cell surface sialoglycopeptide.
While studies concerning mitogenic factors have been an important area of research for many years, much less is understood about the mechanisms of action of cell surface growth inhibitors. We have purified an 18 kDa cell surface sialoglycopeptide growth inhibitor (CeReS-18) which can reversibly inhibit the proliferation of diverse cell types. The studies discussed in this article show that three mouse keratinocyte cell lines exhibit sixty-fold greater sensitivity than other fibroblasts and epithelial-like cells to CeReS-18-induced growth inhibition. Growth inhibition induced by CeReS-18 treatment is a reversible process, and the three mouse keratinocyte cell lines exhibited either single or multiple cell cycle arrest points, although a predominantly G0/G1 cell cycle arrest point was exhibited in Swiss 3T3 fibroblasts. The sensitivity of the mouse keratinocyte cell lines to CeReS-18-induced growth inhibition was not affected by the degree of tumorigenic progression in the cell lines and was not due to differences in CeReS-18 binding affinity or number of cell surface receptors per cell. However, the sensitivity of both murine fibroblasts and keratinocytes could be altered by changing the extracellular calcium concentration, such that increased extracellular calcium concentrations resulted in decreased sensitivity to CeReS-18-induced proliferation inhibition. Thus the increased sensitivity of the murine keratinocyte cell lines to CeReS-18 could be ascribed to the low calcium concentration used in their propagation. Studies are currently under way investigating the role of calcium in CeReS-18-induced growth arrest. The CeReS-18 may serve as a very useful tool to study negative growth control and the signal transduction events associated with cell cycling.
Center for Basic Cancer Research, Kansas State University, Manhattan 66506-4903.
N A
NA
Betz
H K
HK
Fattaey
T C
TC
Johnson
D016475:3T3 Cells; D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D002417:Cattle; D002453:Cell Cycle / Q000187:drug effects; D006131:Growth Inhibitors; D066298:In Vitro Techniques; D015603:Keratinocytes / Q000166:cytology* / Q000187:drug effects; D051379:Mice; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology*; D012795:Sialoglycoproteins / Q000494:pharmacology*
D006131:Growth Inhibitors; D011500:Protein Synthesis Inhibitors; D012795:Sialoglycoproteins; C047908:sialoglycopeptide inhibitor protein, bovine; D002118:Calcium